SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-270436
Filing Date
2023-11-03
Accepted
2023-11-03 16:30:56
Documents
1
Group Members
FAIRMOUNT HEALTHCARE FUND GP LLCFAIRMOUNT HEALTHCARE FUND II GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d563332dsc13da.htm SC 13D/A 77657
  Complete submission text file 0001193125-23-270436.txt   79637
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88625 | Film No.: 231376838
SIC: 8071 Services-Medical Laboratories

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

IRS No.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A